Stereotactic fractionated radiotherapy for the treatment of benign meningiomas
Charles Candish(Clinical Trial Investigators), Monty Martin(BC Cancer Agency), Ermias Gete(BC Cancer Agency), Richard Lee, Michael McKenzie(Provincial Health Services Authority), Roy Ma(BC Cancer Agency), James L. Robar(BC Cancer Agency), Brenda Clark, E. Vollans(BC Cancer Agency)
International Journal of Radiation Oncology*Biology*Physics
October 26, 2006
Cited by 8
Related Papers
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2016|736
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2017|319